Form D · Pharmaceuticals
NP-C Therapeutics, LLC
King Of Prussia, PA · CIK 0001671127
Offering snapshot reported Apr 1, 2016 · SEC filing
- Reported sold
- $175K Offering amount: $700K
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Mar 18, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 1, 2016 | Initial | $175,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-260532
Source: Form D, filed Apr 1, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Claypool | Director, Executive |
| Ivan Joseph | Executive |
| Dennis Willson | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
640 Freedom Business Center Drive Suite 210
King Of Prussia, PA, 19406
King Of Prussia, PA, 19406